Clinical and Molecular Hepatology (Clin Mol Hepatol, CMH)

Letter to the Editor

Clinical significance of the discrepancy between radiological findings and biochemical responses in atezolizumab plus bevacizumab for hepatocellular carcinoma

Hideki Iwamoto, Shigeo Shimose, Takashi Niizeki, Hironori Koga, Takuji Torimura

Clin Mol Hepatol. 2022;28(3):575-579. Published online April 21, 2022

DOI: https://doi.org/10.3350/cmh.2022.0047

View: 1040 Download: 152

Effects of interleukin-17 inhibitors on hepatic fibrosis index in patients with psoriasis and metabolic dysfunction-associated fatty liver disease: Directed acyclic graphs

Saori Takamura, Yuichi Teraki, Eri Katayama, Takumi Kawaguchi, Machiko Kawaguchi, Dan Nakano, Tsubasa Tsutsumi, Sumiko Nagoshi, Takekuni Nakama, Takuji Torimura

Clin Mol Hepatol. 2022;28(2):269-272. Published online February 15, 2022

DOI: https://doi.org/10.3350/cmh.2022.0040

View: 1579 Download: 203

Reply: Letter: cervicocerebral atherosclerosis and its hepatic and coronary risk factors in patients with liver cirrhosis

Jihyun An, Ju Hyun Shim

Clin Mol Hepatol. 2022;28(2):267-268. Published online January 18, 2022

DOI: https://doi.org/10.3350/cmh.2022.0013

View: 1090 Download: 30

Letter: cervicocerebral atherosclerosis and its hepatic and coronary risk factors in patients with liver cirrhosis

Yi-Chun Huang, Chih-Wei Chen, James Chun-Chung Wei

Clin Mol Hepatol. 2022;28(2):265-266. Published online January 4, 2022

DOI: https://doi.org/10.3350/cmh.2021.0412

View: 4499 Download: 30 Citation: 1

Impact of branched-chain amino acids and frailty on the management of lenvatinib-related fatigue in patients with hepatocellular carcinoma

Shigeo Shimose, Shunji Koya, Takumi Kawaguchi, Keisuke Hirota, Sachiyo Yoshio, Takashi Niizeki, Hiroo Matsuse, Takuji Torimura

Clin Mol Hepatol. 2021;27(4):616-619. Published online September 13, 2021

DOI: https://doi.org/10.3350/cmh.2021.0258

View: 2130 Download: 166

The major diagnostic role of autoantibodies in the diagnosis of autoimmune hepatitis, a disease of all ages

Linda Beenet

Clin Mol Hepatol. 2021;27(3):510-511. Published online March 22, 2021

DOI: https://doi.org/10.3350/cmh.2021.0058

View: 1869 Download: 121 Citation: 1

Clinical and serological prognostic markers in primary biliary cholangitis

Markus Wilhelmi

Clin Mol Hepatol. 2021;27(2):360-361. Published online March 23, 2021

DOI: https://doi.org/10.3350/cmh.2021.0088

View: 1772 Download: 87

A dilemma that probably would never resolve

Ravi Thanage, Shubham Jain, Sanjay Chandnani, Pravin Rathi

Clin Mol Hepatol. 2021;27(1):219-220. Published online December 3, 2020

DOI: https://doi.org/10.3350/cmh.2020.0274

View: 1714 Download: 59

Lean non-alcoholic fatty liver disease: Is there a place for novel antidiabetics in the therapeutic management of this underappreciated “enemy”?

Dimitrios Patoulias, Michael Doumas

Clin Mol Hepatol. 2020;26(4):582-583. Published online September 25, 2020

DOI: https://doi.org/10.3350/cmh.2020.0264

View: 1902 Download: 59

Phosphoinositide 3-kinase inhibitors are effective therapeutic drugs for the treatment of hepatocellular carcinoma?

Jeong Su Park, Soo Han Bae

Clin Mol Hepatol. 2020;26(4):577-578. Published online September 17, 2020

DOI: https://doi.org/10.3350/cmh.2020.0143

View: 1962 Download: 56 Citation: 1

Macro-aspartate aminotransferase in a healthy woman

Maria Lorubbio, Agostino Ognibene, Benedetta Salvadori, Alessandra Fanelli, Giacomo Laffi

Clin Mol Hepatol. 2020;26(3):378-381. Published online June 23, 2020

DOI: https://doi.org/10.3350/cmh.2020.0069

View: 2636 Download: 93 Citation: 1

How does low-level viremia affect the prognosis of patients with chronic hepatitis B?

Hye Won Lee, Beom Kyung Kim

Clin Mol Hepatol. 2020;26(3):376-377. Published online June 11, 2020

DOI: https://doi.org/10.3350/cmh.2020.0121

View: 2538 Download: 98 Citation: 1

Limited expression of toll-like receptor 9 on T cells and its functional consequences in patients with nonalcoholic fatty liver disease

Jung Hwan Yu

Clin Mol Hepatol. 2020;26(2):240-241. Published online March 23, 2020

DOI: https://doi.org/10.3350/cmh.2020.0048

View: 2368 Download: 39

Intricate interpretation of etiology-specific outcome comparison in patients with hepatocellular carcinoma

Hwi Young Kim, Jean-François Dufour

Clin Mol Hepatol. 2020;26(2):238-239. Published online March 18, 2020

DOI: https://doi.org/10.3350/cmh.2020.0051

View: 2458 Download: 50

Does limited expression of toll-like receptor 9 actually contribute to T cell activation and liver damage in nonalcoholic steatohepatitis?

Hyuk Soo Eun

Clin Mol Hepatol. 2020;26(2):236-237. Published online April 7, 2020

DOI: https://doi.org/10.3350/cmh.2020.0040

View: 2082 Download: 43

A challenge in distinguishing between acute hepatitis B and acute exacerbation of chronic hepatitis B

Yang-Hyun Baek

Clin Mol Hepatol. 2020;26(2):233-235. Published online April 7, 2020

DOI: https://doi.org/10.3350/cmh.2020.0039

View: 2455 Download: 82

Fibrolamellar hepatocellular carcinoma-related hyperammonemic encephalopathy: Up to now and next steps

Rodrigo Cañada Trofo Surjan, Elizabeth Santana dos Santos, Sergio do Prado Silveira, Fabio Ferrari Makdissi, Marcel Autran Cesar Machado

Clin Mol Hepatol. 2020;26(2):231-232. Published online November 4, 2019

DOI: https://doi.org/10.3350/cmh.2019.0084

View: 2688 Download: 79 Citation: 1

Multimodal sequential treatment for occluded TIPS: Case report and review of literature

Nicoletta De Matthaeis, Carmine Di Stasi, Fabrizio Pizzolante, Riccardo Manfredi, Gian Ludovico Rapaccini, Luca Miele

Clin Mol Hepatol. 2020;26(2):227-230. Published online November 18, 2019

DOI: https://doi.org/10.3350/cmh.2019.0056

View: 3598 Download: 125

Clinical characteristics of portal hypertension complicated by gastroesophageal varices in patients with myeloproliferative neoplasms

Jaejun Lee, Pil Soo Sung, Ki-Seong Eom, Hyun Yang, Soon Kyu Lee, Aung Hlaing Bwa, Angelo Lozada, Jeong Won Jang, Si Hyun Bae, Jong Young Choi, Seung Kew Yoon

Clin Mol Hepatol. 2020;26(1):78-82. Published online November 26, 2019

DOI: https://doi.org/10.3350/cmh.2019.0078

View: 3754 Download: 132 Citation: 1

Hyperammonemic encephalopathy: An unusual presentation of fibrolamellar hepatocellular carcinoma

Nimish Thakral, Douglas A. Simonetto

Clin Mol Hepatol. 2020;26(1):74-77. Published online August 16, 2019

DOI: https://doi.org/10.3350/cmh.2018.0042

View: 4431 Download: 123 Citations: 7

The management of polycystic liver disease by tolvaptan

Tsuneo Takenaka, Soichiro Miura, Masaki Kitajima

Clin Mol Hepatol. 2020;26(1):70-73. Published online June 13, 2019

DOI: https://doi.org/10.3350/cmh.2019.0026

View: 5545 Download: 217 Citations: 5

Transjugular intrahepatic portosystemic shunt assisted with trans-splenic access

Zhang Cheng, Feng Wang, Jianfei Liu

Clin Mol Hepatol. 2019;25(4):417-419. Published online June 19, 2019

DOI: https://doi.org/10.3350/cmh.2019.0030

View: 2764 Download: 101

Carnitine palmitoyl transferase 1A deficiency in an adult with recurrent severe steatohepatitis aggravated by high pathologic or physiologic demands: A roller-coaster for internists

Prasit Phowthongkum, Kanya Suphapeetiporn, Vorasuk Shotelersuk

Clin Mol Hepatol. 2019;25(4):412-416. Published online June 24, 2019

DOI: https://doi.org/10.3350/cmh.2018.0114

View: 3408 Download: 108 Citation: 1

Persistent elevation of aminotransferases in liver transplant in association with chronic norovirus infection

Ammar Abdulaziz Khayat, Grzegorz W Telega

Clin Mol Hepatol. 2019;25(4):408-411. Published online May 7, 2019

DOI: https://doi.org/10.3350/cmh.2019.0018

View: 3275 Download: 70 Citation: 1

How long should physicians follow up with patients after curative treatment for hepatocellular carcinoma?

Bo Hyun Kim

Clin Mol Hepatol. 2019;26(4):579-581. Published online September 23, 2020

DOI: https://doi.org/10.3350/cmh.2020.0200

View: 1989 Download: 61 Citations: 2

Serum leptin in non-alcoholic fatty liver disease: Ambiguous clinical implications concerning cardiovascular disease

Dimitrios Patoulias, Konstantinos Imprialos, Konstantinos Stavropoulos, Michael Doumas

Clin Mol Hepatol. 2019;25(3):331-332. Published online May 30, 2019

DOI: https://doi.org/10.3350/cmh.2019.0034

View: 2712 Download: 52

Letter to the editor

Ombitasvir/paritaprevir/ritonavir+dasabuvir and ribavirin associated drug-induced liver injury and syndrome of inappropriate secretion of anti-diuretic hormone: A case report

Rahul Kumar, John Chen Hsiang, Jessica Tan, Prem Harichander Thurairajah

Clin Mol Hepatol. 2019;25(3):326-330. Published online December 4, 2018

DOI: https://doi.org/10.3350/cmh.2018.0063

View: 9742 Download: 94 Citations: 3

VIEKIRA PAK associated drug-induced interstitial lung disease: Case series with systematic review of literature

Yu Jun Wong, Si Yuan Chew, John Chen Hsiang, Prem Harichander Thurairajah, Rahul Kumar, Eng Kiong Teo, Roshni Sadashiv Gokhale, Imran Bin Mohamed Noor, Jessica Tan

Clin Mol Hepatol. 2019;25(2):218-222. Published online September 6, 2018

DOI: https://doi.org/10.3350/cmh.2018.0017

View: 8875 Download: 114 Citations: 2

Letter to the Editor

Biochemical profile in an infant with neonatal hemochromatosis shows evidence of impairment of mitochondrial long-chain fatty acid oxidation

Karina Lucio de Medeiros Bastos, Caio Robledo Quaio, Fabiana Roberto Lima, Iana Manuelle Araújo, Candice Alves Tavares Araújo, Flávia Balbo Piazzon, Ismael Dale Cotrim Guerreiro da Silva, Gabriel Nuncio Benevides, Ana Cristina Tannuri, Uenis Tannuri, Ramiro Anthero Azevedo, Chong Ae Kim

Clin Mol Hepatol. 2019;25(1):86-91. Published online August 28, 2018

DOI: https://doi.org/10.3350/cmh.2018.0005

View: 5664 Download: 134 Citation: 1

Transarterial embolization for the treatment of complicated liver hemangiomas: A report of two cases and review of the literature

Maria Kalogirou, Danai Chourmouzi, Ioannis Dedes, Stefania Kiapidou, Evangelos Akriviadis, Emmanouil Sinakos

Clin Mol Hepatol. 2018;24(3):345-349. Published online June 11, 2018

DOI: https://doi.org/10.3350/cmh.2017.0075

View: 6106 Download: 109

Viewed By 11264	Crosstalk between tumor-associated macrophages and neighboring cells in hepatocellular carcinoma
Viewed By 4887	A cost-effectiveness study of universal screening for hepatitis C virus infection in South Korea: A societal perspective
Viewed By 3925	KASL clinical practice guidelines for management of chronic hepatitis B
Viewed By 2815	Association between serum tumor necrosis factor-α and sarcopenia in liver cirrhosis
Viewed By 2702	KASL clinical practice guidelines: Management of nonalcoholic fatty liver disease

Cited By 45	Trends in the prevalence of chronic liver disease in the Korean adult population, 1998–2017
Cited By 38	KASL clinical practice guidelines: Management of nonalcoholic fatty liver disease
Cited By 35	Application of transient elastography in nonalcoholic fatty liver disease
Cited By 33	KASL clinical practice guidelines for liver cirrhosis: Varices, hepatic encephalopathy, and related complications
Cited By 33	Comparison of clinical practice guidelines for the management of chronic hepatitis B: When to start, when to change, and when to stop

Letter to the Editor